Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation

Biochemistry. 1992 May 12;31(18):4473-9. doi: 10.1021/bi00133a013.

Abstract

Steady-state and pre-steady-state kinetic constants were determined for reverse transcriptase catalyzed incorporation of nucleotides and nucleotide analogues into defined-sequence DNA primed-RNA templates. 3'-Azido-3'-deoxythymidine 5'-triphosphate (AZTTP) was almost as efficient a substrate (kcat/Km) as dTTP for the enzyme. In contrast, the four 2',3'-dideoxynucleoside 5'-triphosphates and 3'-deoxy-2',3'-didehydrothymidine 5'-triphosphate (d4TTP) were 6-30-fold less efficient substrates of the enzyme. The kcat values for all nucleotide analogues were similar, consistent with a kinetic model in which the steady-state rate-limiting step was dissociation of the template-primer from the enzyme [Reardon, J. E., & Miller, W. H. (1990) J. Biol. Chem. 265, 20302-20307]. The pre-steady-state kinetics of single-nucleotide incorporation were consistent with the kinetic model: [formula: see text] where E, TP, and dNTP represent reverse transcriptase, a defined-sequence DNA primed-RNA template, and 2'-deoxynucleoside 5'-triphosphate (or analogue), respectively. The dissociation constant (Kd1) for template-primer binding was 10 nM, and the estimated rate constants for association and dissociation of the enzyme.template-primer complex were 4 x 10(6) M-1 s-1 and 0.04 s-1, respectively. The dissociation constants (Kd2) for dTTP, AZTTP, and 3'-deoxythymidine 5'-triphosphate (ddTTP) were 9, 11, and 4.6 microM, respectively. Thus, the differences in steady-state Km values were not due to differences in binding of the nucleotide analogues to the enzyme. In contrast, the rate-limiting step during single-nucleotide incorporation (kp) was sensitive to the structure of the nucleotide substrate.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH terms

  • Antiviral Agents / pharmacology
  • Base Sequence
  • Binding, Competitive
  • Dideoxynucleotides
  • HIV / enzymology*
  • Molecular Sequence Data
  • Oligonucleotide Probes / chemistry
  • RNA-Directed DNA Polymerase / chemistry*
  • Reverse Transcriptase Inhibitors
  • Templates, Genetic
  • Thionucleotides / chemistry
  • Thymine Nucleotides / pharmacokinetics*
  • Thymine Nucleotides / pharmacology
  • Zidovudine / analogs & derivatives
  • Zidovudine / pharmacology

Substances

  • Antiviral Agents
  • Dideoxynucleotides
  • Oligonucleotide Probes
  • Reverse Transcriptase Inhibitors
  • Thionucleotides
  • Thymine Nucleotides
  • Zidovudine
  • zidovudine triphosphate
  • RNA-Directed DNA Polymerase